Company
Gour Medical SA
Headquarters: Paris, France
CEO: Mr. Serge Goldner
Market Cap
€536,272
EUR as of July 1, 2023
US$585,385
Gour Medical SA Categories
France Healthcare Drug Manufacturers—Specialty & GenericFrance Healthcare France Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Gour Medical SA engages in the development and marketing of various veterinary solutions for companion animals. It provides cannabidiol-based solutions for pets under the WEEDLEY brand. The company was founded in 2014 and is based in Paris, France.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Gour Medical SA has the following listings and related stock indices.
Stock: Euronext: MLGML wb_incandescent